About Medgold Resources Corp. (CVE:MED)
Medgold Resources Corp., an exploration stage company, engages in the acquisition and exploration of resource properties primarily in Portugal, Serbia, and Spain. It explores for gold, and precious and base metals. The companys properties include Klondike project that comprises Lagares, Valongo, Ponte da Barca, Balazar, and Castelo de Paiva exploration licenses, as well as Boticas-Chaves and Valongo Belt projects located in Portugal. It also holds interest in six exploration licenses for gold-silver epithermal and gold-dominant porphyry systems in the Republic of Serbia. The company has strategic alliance agreement with Fortuna Silver Mines Inc. to identify Tlamino project in Serbia; and Radius Gold Inc. Medgold Resources Corp. is headquartered in Vancouver, Canada.
Industry, Sector and Symbol:
- Industry: Industrial Metals & Minerals
- Sub-Industry: N/A
- Sector: Basic Materials
- Symbol: CVE:MED
- CUSIP: N/A
- Web: www.medgoldresources.com
- Trailing EPS: C($0.03)
- Return on Equity: -91.94%
- Return on Assets: -83.40%
- Outstanding Shares: 85,014,000
Frequently Asked Questions for Medgold Resources Corp. (CVE:MED)
What is Medgold Resources Corp.'s stock symbol?
Medgold Resources Corp. trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MED."
When will Medgold Resources Corp. make its next earnings announcement?
Who are some of Medgold Resources Corp.'s key competitors?
Who are Medgold Resources Corp.'s key executives?
Medgold Resources Corp.'s management team includes the folowing people:
- Daniel P. James, President, Director (Age 35)
- Simon T. Ridgway, Chief Executive Officer, Director (Age 68)
- Ralph Rushton, Director
- David John Hall, Independent Director
- Jeremy John Martin, Independent Director
- Michael B Skead, Independent Director
How do I buy Medgold Resources Corp. stock?
Shares of Medgold Resources Corp. and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Medgold Resources Corp.'s stock price today?
One share of Medgold Resources Corp. stock can currently be purchased for approximately C$0.16.
How big of a company is Medgold Resources Corp.?
Medgold Resources Corp. has a market capitalization of C$14.31 million.
How can I contact Medgold Resources Corp.?
Medgold Resources Corp.'s mailing address is 200 Burrard St Suite 650, VANCOUVER, BC V6C 3L6, Canada. The company can be reached via phone at +1-604-8015432.
MarketBeat Community Rating for Medgold Resources Corp. (CVE MED)MarketBeat's community ratings are surveys of what our community members think about Medgold Resources Corp. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for Medgold Resources Corp. (CVE:MED) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Analysts' Consensus Price Target: ||N/A|
Consensus Price Target History for Medgold Resources Corp. (CVE:MED)
Analysts' Ratings History for Medgold Resources Corp. (CVE:MED)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Medgold Resources Corp. (CVE:MED)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Medgold Resources Corp. (CVE:MED)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Medgold Resources Corp. (CVE:MED)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Medgold Resources Corp. (CVE MED)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Medgold Resources Corp. (CVE:MED)
Latest Headlines for Medgold Resources Corp. (CVE MED)
No headlines for this company have been tracked by MarketBeat.com
Financials are not available for this stock.
Medgold Resources Corp. (CVE MED) Chart for Saturday, November, 18, 2017